ACTA1 and myocardial infarction: Similarly, at day 7 post-MI/R, SalB administration significantly increased CD31-positive cells and α-SMA-positive cells within the myocardial infarct border area of GLSWT mice, indicating enhanced EC number and blood vessel density.